Annual Drug Patent Expirations for CARNEXIV
Carnexiv is a drug marketed by Lundbeck Pharms Llc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
Drug patent litigation for CARNEXIV.
This drug has seventy-one patent family members in twenty-one countries.
The generic ingredient in CARNEXIV is carbamazepine. One supplier is listed for this compound. Additional details are available on the carbamazepine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
